BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38145503)

  • 1. An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?
    Bardhan M; Dey D; Suresh V; Javed B; Venur VA; Joe N; Kalidindi R; Ozair A; Khan M; Mahtani R; Lo S; Odia Y; Ahluwalia MS
    Expert Rev Neurother; 2024; 24(1):77-103. PubMed ID: 38145503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of neoplastic meningitis.
    Roth P; Weller M
    Chin Clin Oncol; 2015 Jun; 4(2):26. PubMed ID: 26112812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review.
    Maur M; Omarini C; Piacentini F; Fontana A; Pettorelli E; Cascinu S
    Am J Case Rep; 2017 Feb; 18():208-211. PubMed ID: 28242865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist].
    Rudnicka H; Niwińska A; Gruszfeld A; Pieńkowski T
    Neurol Neurochir Pol; 2003; 37(4):811-24. PubMed ID: 14746241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of leptomeningeal metastasis in breast cancer.
    Assi HI; Mahmoud T; Saadeh FS; El Darsa H
    Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
    Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
    Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoplastic Meningitis Due to Lung, Breast, and Melanoma Metastases.
    Le Rhun E; Taillibert S; Chamberlain MC
    Cancer Control; 2017 Jan; 24(1):22-32. PubMed ID: 28178709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment modalities for leptomeningeal metastases.
    Shapiro WR; Johanson CE; Boogerd W
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S46-54. PubMed ID: 19660683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast leptomeningeal disease: a review of current practices and updates on management.
    Figura NB; Rizk VT; Armaghani AJ; Arrington JA; Etame AB; Han HS; Czerniecki BJ; Forsyth PA; Ahmed KA
    Breast Cancer Res Treat; 2019 Sep; 177(2):277-294. PubMed ID: 31209686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours.
    Beauchesne P
    Lancet Oncol; 2010 Sep; 11(9):871-9. PubMed ID: 20598636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
    Kak M; Nanda R; Ramsdale EE; Lukas RV
    J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for leptomeningeal disease in breast cancer.
    Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
    Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal carcinomatosis in patients with breast cancer.
    Franzoi MA; Hortobagyi GN
    Crit Rev Oncol Hematol; 2019 Mar; 135():85-94. PubMed ID: 30819451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era.
    Remon J; Le Rhun E; Besse B
    Cancer Treat Rev; 2017 Feb; 53():128-137. PubMed ID: 28110254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study.
    Lin N; Dunn IF; Glantz M; Allison DL; Jensen R; Johnson MD; Friedlander RM; Kesari S
    J Neurosurg; 2011 Oct; 115(4):730-6. PubMed ID: 21721878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Options for Leptomeningeal Metastases of Solid Cancers: Literature Review and Personal Experience.
    Kondoh T; Sonoda T
    Acta Neurochir Suppl; 2021; 128():71-84. PubMed ID: 34191063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review.
    Fernandes L; de Matos LV; Cardoso D; Saraiva M; Medeiros-Mirra R; Coelho A; Miranda H; Martins A
    CNS Oncol; 2020 Dec; 9(4):CNS65. PubMed ID: 33078616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
    Gaviani P; Silvani A; Corsini E; Erbetta A; Salmaggi A
    Neurol Sci; 2009 Jun; 30(3):251-4. PubMed ID: 19259616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and prognostic factors in patients with leptomeningeal metastases].
    Li N; Yang BY; Li JL; Zhu JQ; Zou BH; Wang YF; Yu L; Yao XY
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):867-70. PubMed ID: 24447488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptomeningeal metastasis from solid tumors.
    Thakkar JP; Kumthekar P; Dixit KS; Stupp R; Lukas RV
    J Neurol Sci; 2020 Apr; 411():116706. PubMed ID: 32007755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.